STXS logo

Stereotaxis, Inc. Stock Price

NYSEAM:STXS Community·US$254.1m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

STXS Share Price Performance

US$2.85
0.59 (26.11%)
US$4.50
Fair Value
US$2.85
0.59 (26.11%)
36.7% undervalued intrinsic discount
US$4.50
Fair Value
Price US$2.85
AnalystConsensusTarget US$4.50

STXS Community Narratives

AnalystConsensusTarget·
Fair Value US$4.5 36.7% undervalued intrinsic discount

Robotic Catheters And Digital Surgery Will Boost Adoption

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

1 Risk
2 Rewards

Stereotaxis, Inc. Key Details

US$31.8m

Revenue

US$15.8m

Cost of Revenue

US$16.0m

Gross Profit

US$40.6m

Other Expenses

-US$24.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.27
50.17%
-77.46%
0%
View Full Analysis

About STXS

Founded
1990
Employees
139
CEO
David Fischel
WebsiteView website
www.stereotaxis.com

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Recent STXS News & Updates

Recent updates

No updates